Bausch & Lomb (BLCO) Income from Continuing Operations (2021 - 2026)
Bausch & Lomb (BLCO) posted Income from Continuing Operations of 70000000.0 for Q1 2026, down 20.69% on a QoQ basis from 58000000.0 in Q4 2025, and up 66.82% year-over-year from 41960227.27 in Q1 2025.
Bausch & Lomb (BLCO) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Bausch & Lomb's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 70000000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 66.82% year-over-year to 70000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 211000000.0 (up 40.23% YoY) and the FY2025 annual result came in at 352000000.0, down 15.41% from the prior year.
- Income from Continuing Operations was 70000000.0 for Q1 2026 at Bausch & Lomb, down from 58000000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 23000000.0 in Q1 2022 and bottomed at 211000000.0 in Q1 2025.
- A 5-year average of 60000000.0 and a median of 54500000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 110.0% — and 2025, when it tumbled 2800.0%.
- Bausch & Lomb's Income from Continuing Operations stood at 15000000.0 in 2022, then plunged by 240.0% to 51000000.0 in 2023, then jumped by 96.08% to 2000000.0 in 2024, then tumbled by 2800.0% to 58000000.0 in 2025, then retreated by 20.69% to 70000000.0 in 2026.
- Business Quant data shows BLCO's Income from Continuing Operations at 70000000.0 in Q1 2026, 58000000.0 in Q4 2025, and 25000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | -70.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.00 Mn |
| Dec 31, 2025 | -58.00 Mn |
| Sep 30, 2025 | -25.00 Mn |
| Jun 30, 2025 | -58.00 Mn |
| Mar 31, 2025 | -211.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -148.00 Mn |
| Mar 31, 2024 | -163.00 Mn |
| Dec 31, 2023 | -51.00 Mn |
| Sep 30, 2023 | -80.00 Mn |
| Jun 30, 2023 | -29.00 Mn |
| Mar 31, 2023 | -88.00 Mn |
| Sep 30, 2022 | -15.00 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 23.00 Mn |
| Dec 31, 2021 | 54.00 Mn |
| Sep 30, 2021 | 63.00 Mn |
| Jun 30, 2021 | 46.00 Mn |
| Mar 31, 2021 | 30.00 Mn |